Daily News - 2 September 2025
About this episode
Three new headlines today: Phasecraft (UK) raises $34M for hardware-agnostic quantum algorithms; Tangany (Germany) €10M Series A for MiCA-compliant digital custody; CHARM Therapeutics (UK) €68.5M Series B for menin inhibitor on resistant tumors. In this episode the main theme is Startup Financing. Central thesis: Three European startups raise significant funds. What specifically do we discuss? Phasecraft is a British startup developing hardware-agnostic quantum algorithms. Tangany is a German startup offering MiCA-compliant digital custody solutions. CHARM Therapeutics is a British startup focusing on inhibitors for resistant tumors. European Perspective: These startups represent technological innovation and regulatory compliance in Europe, rapidly growing and highly relevant sectors. Strategic Implications: Investments in advanced technologies and regulatory compliance. Key Players: Phasecraft, Tangany, CHARM Therapeutics.
Europe's most interesting startup stories. Every week.
No spam. Unsubscribe anytime.
Main news
2. Phasecraft_website
4. Tangany_website
6. CHARM_Therapeutics_website
Startups mentioned
CHARM Therapeutics
CHARM Therapeutics uses DragonFold, a 3D deep learning-based protein-ligand prediction AI platform, to identify and validate therapeutic molecules with high specificity against complex protein targets.
Tangany
Tangany provides banks, wealth managers and fintechs with API infrastructure for the secure custody of cryptocurrencies and digital assets, real asset tokenisation and compliance with European digital asset regulation.
Why they matter
Investimenti in tecnologie avanzate e compliance normativa.